Miláček čtenářů je právě vyprodaný
Více o knize
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Nákup knihy
The Pharmagellan Guide to Biotech Forecasting and Valuation, Andrew Matthews, Frank S. David, Seth Robey
- Jazyk
- Rok vydání
- 2017
- product-detail.submit-box.info.binding
- (měkká)
Jakmile se objeví, pošleme e-mail.
Doručení
Platební metody
Tady nám chybí tvá recenze.
- Titul
- The Pharmagellan Guide to Biotech Forecasting and Valuation
- Jazyk
- anglicky
- Autoři
- Andrew Matthews, Frank S. David, Seth Robey
- Vydavatel
- Pharmagellan
- Rok vydání
- 2017
- Vazba
- měkká
- Počet stran
- 138
- ISBN10
- 099840750X
- ISBN13
- 9780998407500
- Série
- Hodnocení
- 4,3 z 5
- Anotace
- If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.